Drug Type Fusion protein |
Synonyms |
Target |
Mechanism IL-15 modulators(Interleukin-15 modulators), IL-15Rα modulators(Interleukin-15 receptor subunit alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 1 | CN | 05 Jun 2023 | |
Colorectal Cancer | Phase 1 | AU | 05 Jun 2023 | |
Melanoma | Phase 1 | CN | 05 Jun 2023 | |
Melanoma | Phase 1 | AU | 05 Jun 2023 | |
Non-Small Cell Lung Cancer | Phase 1 | AU | 05 Jun 2023 | |
Non-Small Cell Lung Cancer | Phase 1 | CN | 05 Jun 2023 | |
Squamous Cell Carcinoma of Head and Neck | Phase 1 | CN | 05 Jun 2023 | |
Squamous Cell Carcinoma of Head and Neck | Phase 1 | AU | 05 Jun 2023 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 1 | AU | 05 Jun 2023 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 1 | CN | 05 Jun 2023 |